Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease. - Wikidata - wikimedia - TriplyDB

Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.

Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.

http://www.wikidata.org/entity/Q38022258

about

Clinical and genetic factors predicting response to therapy in patients with Crohn's disease.Personalizing health care: feasibility and future implications.An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics.Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD.Predicting outcomes in acute severe ulcerative colitis.Update on thiopurine pharmacogenetics in inflammatory bowel disease.Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management.NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases.Monitoring thiopurine metabolites in inflammatory bowel disease.Pharmacogenetics of inflammatory bowel disease.Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study.Genetic polymorphism inATG16L1gene influences the response to adalimumab in Crohn's disease patients

P2860

Q33695605-381E35A6-8E0B-4DDC-BA02-6AA24CE71A79 Q34938911-363B0D4F-2C6F-4005-84FC-F2031BAF4B2E Q35846531-81F1EE44-02A1-4577-A463-63283328012E Q37572837-52DFF6E0-514E-4070-931F-20E7EC918B03 Q38179509-C6D8F6BA-959C-49E6-A73C-54F40FF63F4C Q38253469-D6203338-9515-4A23-946A-6E51C18C86E4 Q38286166-5ABE05D9-D282-4A8F-A9C6-A28C6A7A9D5E Q38525578-C38D79F1-8039-4D8D-A688-730F1DAAC81D Q38619950-64D91847-68F8-4351-B410-E877E4A394A6 Q41080533-47D743B3-1030-4C7A-8E9A-1BFF1CFFBDEE Q41642129-3F88FB27-5FEA-44E7-A99E-097FDD8D1951 Q41673937-7D4E5D9D-5D43-4074-B680-03F5881BDD1D Q55259199-68DAD652-D4F0-4B56-A633-A4414131E626 Q58862198-DE8D2103-9303-434E-940A-E031FC42E935

P2860

Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.

http://www.wikidata.org/entity/Q38022258

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.

@en

type

label

Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.

@en

prefLabel

Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.

@en

P1433

Q38022258-8A1EA8F3-6574-4541-94D3-C8F0085DA559

P1476

Q38022258-ED7E83EB-C16A-4FCA-A91E-7BBDB3C0AD6D

P2093

Q38022258-D23779BA-C981-4498-AFC9-9A4FA4FA874C

Q38022258-E56E2A67-1391-4F73-9B68-0F9AFB00F773

P2860

Q38022258-0402DB5D-2449-456F-B22B-D3B62A5AA00C

Q38022258-0D58AE14-4CEA-4B13-AB68-3DC441CD5D3D

Q38022258-0DA559A2-4629-4D97-A354-8D0039F3446C

Q38022258-128DA96F-9BEA-4D16-AEBD-B621DE40CF64

Q38022258-1603D293-905C-43E0-A8A8-D976F602A527

Q38022258-1B2644E5-838F-4320-93F7-3819BCEDCCAF

Q38022258-1B600738-447F-4FA3-B234-7EC326841927

Q38022258-20119299-7D2E-46F6-981B-B97318D9EBFE

Q38022258-222DF83A-1BA8-4827-AD5F-11944AB53720

Q38022258-26008392-836B-454F-BE71-36E6ECE31566

P304

Q38022258-E3951BC6-6F1B-4D6A-B2BD-47D96A8AB875

P31

Q38022258-6AF9243A-702B-4942-8697-0145D9437283

P356

Q38022258-07733108-C3A0-41DD-B35C-85036EF92562

P433

Q38022258-37DDE7E5-61BB-4315-A3B5-B433E6255A04

P478

Q38022258-42B88084-4FC2-41AA-B797-2DA88203F988

P577

Q38022258-FDBBE489-CD8C-4245-9AB2-8C3710F190D9

P5875

Q38022258-997A0522-A834-471E-BD4A-F08612CEA746

P698

Q38022258-0DB69C60-BEAB-4BC2-90D6-0F6C8D09A35F

P921

Q38022258-338B3AF4-3A36-4B8D-BC5F-892B212480D4

P356

J.1440-1746.2012.07220.X

P1433

Journal of Gastroenterology and Hepatology

P1476

Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.

@en

P2093

Murray L Barclay

http://www.w3.org/2001/XMLSchema#string

Rebecca L Roberts

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletion

The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease

The human glutathione transferase alpha locus: genomic organization of the gene cluster and functional characterization of the genetic polymorphism in the hGSTA1 promoter

Tracing the origin of the most common thiopurine methyltransferase (TPMT) variants: preliminary data from the patterns of haplotypic association with two CA repeats.

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency.

DNA polymorphisms in ITPA including basis of inosine triphosphatase deficiency.

Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-alpha, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy? The Infliximab User Group.

IMPDH1 promoter mutations in a patient exhibiting azathioprine resistance.

P304

1546-1554

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1440-1746.2012.07220.X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228086313

http://www.w3.org/2001/XMLSchema#string

P698

22741564

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease